{
  "cik": 1811063,
  "cik_padded": "0001811063",
  "entityName": "Nuvation Bio Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-085584",
      "filed": "2026-03-02",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 164086000.0,
        "eps_diluted": -0.6,
        "net_income": -204627000.0,
        "operating_cash_flow": -173427000.0,
        "operating_income": -213064000.0,
        "revenue": 62902000.0,
        "stockholders_equity": 305716000.0,
        "total_assets": 594822000.0,
        "total_liabilities": 289106000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.9456685289615199,
        "revenue_growth_yoy": 6.9895846564206785,
        "roa_avg2y": -0.36043394325411643,
        "roa_period_end": -0.3440138394343182,
        "roe_avg2y": -0.5318412899738013,
        "roe_period_end": -0.6693369009145743
      }
    },
    {
      "accn": "0001193125-26-085584",
      "filed": "2026-03-02",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 35723000.0,
        "cost_of_revenue": 7078000.0,
        "eps_diluted": -2.11,
        "gross_profit": 795000.0,
        "net_income": -567939000.0,
        "operating_cash_flow": -130413000.0,
        "operating_income": -592627000.0,
        "revenue": 7873000.0,
        "stockholders_equity": 463788000.0,
        "total_assets": 540626000.0,
        "total_liabilities": 76838000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.10097802616537534,
        "leverage": 0.16567483419148404,
        "roa_avg2y": -0.9774272659214704,
        "roa_period_end": -1.0505210626199997,
        "roe_avg2y": -1.0626507376673433,
        "roe_period_end": -1.2245659654842298
      }
    },
    {
      "accn": "0001193125-26-085584",
      "filed": "2026-03-02",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 42649000.0,
        "eps_diluted": -0.35,
        "gross_profit": 0.0,
        "net_income": -75802000.0,
        "operating_cash_flow": -67999000.0,
        "operating_income": -99822000.0,
        "stockholders_equity": 605122000.0,
        "total_assets": 621484000.0,
        "total_liabilities": 16362000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.02703917557120713,
        "roa_avg2y": -0.11719315875930042,
        "roa_period_end": -0.12196935077974654,
        "roe_avg2y": -0.12030173036300645,
        "roe_period_end": -0.12526730146978626
      }
    },
    {
      "accn": "0000950170-25-034903",
      "filed": "2025-03-06",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 101099000.0,
        "eps_diluted": -0.48,
        "net_income": -104199000.0,
        "operating_cash_flow": -96108000.0,
        "operating_income": -119734000.0,
        "stockholders_equity": 655076000.0,
        "total_assets": 672141000.0,
        "total_liabilities": 17065000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.026050412471224714,
        "roa_avg2y": -0.1438922537720294,
        "roa_period_end": -0.1550255080407236,
        "roe_avg2y": -0.14874171438604555,
        "roe_period_end": -0.15906398646874562
      }
    },
    {
      "accn": "0000950170-24-023247",
      "filed": "2024-02-29",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 132423000.0,
        "eps_diluted": -0.44,
        "net_income": -86848000.0,
        "operating_cash_flow": -68190000.0,
        "operating_income": -93318000.0,
        "stockholders_equity": 745997000.0,
        "total_assets": 776151000.0,
        "total_liabilities": 30154000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.04042107407938638,
        "roa_avg2y": -0.17405402913793674,
        "roa_period_end": -0.11189575224408653,
        "roe_avg2y": -0.18072982402107626,
        "roe_period_end": -0.11641869873471342
      }
    },
    {
      "accn": "0000950170-23-008180",
      "filed": "2023-03-15",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 29755000.0,
        "net_income": -41659000.0,
        "operating_cash_flow": -36529000.0,
        "operating_income": -43551000.0,
        "stockholders_equity": 215084000.0,
        "total_assets": 221792000.0,
        "total_liabilities": 6708000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.031187814993211955,
        "roa_period_end": -0.18782913720963787,
        "roe_avg2y": -0.25033049706758964,
        "roe_period_end": -0.1936871175912667
      }
    },
    {
      "accn": "0000950170-22-002332",
      "filed": "2022-02-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": 117748000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-085584",
    "filed": "2026-03-02",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001811063.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001811063.json"
  },
  "ticker": "NUVB"
}